Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moufida Ben Nasr

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|April 18, 2020
Cell therapy for type 1 diabetesCristian Loretelli, Emma Assi, Andy Joe Seelam, et al.
Pharmacological Research|August 24, 2019
Sitagliptin favorably modulates immune-relevant pathways in human beta cellsAmir Mohammad Malvandi, Cristian Loretelli, Moufida Ben Nasr, et al.
Pharmacological Research|August 10, 2014
The rise, fall, and resurgence of immunotherapy in type 1 diabetesMoufida Ben Nasr, Francesca D'Addio, Vera Usuelli, et al.
Journal of Endocrinological Investigation|March 6, 2017
Immunotherapy for type 1 diabetesDavide Frumento, Moufida Ben Nasr, Basset El Essawy, et al.
Stem Cells Translational Medicine|September 8, 2022
Benefits and Hurdles of Pancreatic β-Cell ReplacementAndrea Mario Bolla, Laura Montefusco, Ida Pastore, et al.
World Journal of Diabetes|July 18, 2015
Explaining the increased mortality in type 1 diabetesChiara Mameli, Sara Mazzantini, Moufida Ben Nasr, et al.
Seminars in Immunology|May 22, 2026
The multifaceted role of B lymphocytes in type 1 diabetesSalma Ayman Khalefa, Moufida Ben Nasr, Vera Usuelli, et al.
Current Opinion in Pharmacology|October 14, 2021
Next-gen therapeutics to spare and expand beta-cell massAndrea Mario Bolla, Vera Usuelli, Moufida Ben Nasr, et al.
Regenerative Medicine|May 12, 2016
The use of hematopoietic stem cells in autoimmune diseasesMoufida Ben Nasr, Roberto Bassi, Vera Usuelli, et al.
Transplantation|May 28, 2021
Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft RejectionVera Usuelli, Cristian Loretelli, Andy Joe Seelam, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|April 18, 2020
Cell therapy for type 1 diabetesCristian Loretelli, Emma Assi, Andy Joe Seelam, et al.
Pharmacological Research|August 24, 2019
Sitagliptin favorably modulates immune-relevant pathways in human beta cellsAmir Mohammad Malvandi, Cristian Loretelli, Moufida Ben Nasr, et al.
Pharmacological Research|August 10, 2014
The rise, fall, and resurgence of immunotherapy in type 1 diabetesMoufida Ben Nasr, Francesca D'Addio, Vera Usuelli, et al.
Journal of Endocrinological Investigation|March 6, 2017
Immunotherapy for type 1 diabetesDavide Frumento, Moufida Ben Nasr, Basset El Essawy, et al.
Stem Cells Translational Medicine|September 8, 2022
Benefits and Hurdles of Pancreatic β-Cell ReplacementAndrea Mario Bolla, Laura Montefusco, Ida Pastore, et al.
World Journal of Diabetes|July 18, 2015
Explaining the increased mortality in type 1 diabetesChiara Mameli, Sara Mazzantini, Moufida Ben Nasr, et al.
Seminars in Immunology|May 22, 2026
The multifaceted role of B lymphocytes in type 1 diabetesSalma Ayman Khalefa, Moufida Ben Nasr, Vera Usuelli, et al.
Current Opinion in Pharmacology|October 14, 2021
Next-gen therapeutics to spare and expand beta-cell massAndrea Mario Bolla, Vera Usuelli, Moufida Ben Nasr, et al.
Regenerative Medicine|May 12, 2016
The use of hematopoietic stem cells in autoimmune diseasesMoufida Ben Nasr, Roberto Bassi, Vera Usuelli, et al.
Transplantation|May 28, 2021
Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft RejectionVera Usuelli, Cristian Loretelli, Andy Joe Seelam, et al.
Pageof 6